China Designates BCI as National Strategy, First Commercial Device Approved
China has formally elevated BCI to a national strategic industry while simultaneously approving the first commercial invasive device, a coordinated policy and regulatory move that puts it ahead of Neuralink in the commercial timeline.
Reporting from 1 sources: ASCII.jp.
China has designated brain-computer interface technology as a key industry in its five-year plan, making it a national strategic priority. On the same day, a Shanghai startup received approval for NEO, a minimally invasive BCI device placed on the brain's protective membrane, claiming the world's first commercial invasive BCI ahead of Elon Musk's Neuralink.
The Chinese government designated brain-computer interface technology as a key industry in its five-year plan on the same day regulators approved the first commercial invasive BCI device. The device, called NEO, was developed by a Shanghai startup and uses a minimally invasive design placed on the brain's protective membrane. It was approved by Chinese authorities in March 2026. The simultaneous policy announcement and device approval position China as the first country to commercialize invasive BCI technology, ahead of Elon Musk's Neuralink, which has not yet received similar commercial clearance.
Synthesized by Yomimono from the 1 cited source below, including Japanese-language reporting where cited, then editorially reviewed before publishing.
Sources
- ASCII.jp 中国、BCIを国家戦略に 世界初の商用化で イーロン・マスクにも先行